taking tirzepatide and retatrutide together vs. Tirzepatide: What's The Difference? – Forbes Health Retatrutide vs. Tirzepatide: Dual vs.

UCSF Health recommends regular leg exercises as part of managing venous disease

We discuss the use of glucagon-like peptide-1 (GLP-1) analogues as monotherapy and unimolecular dual or triple agonists that exploit the GLP-1 receptor and/or the gastric inhibitory peptide (GIP) receptor and/or the glucagon receptor

Reported incidences in those receiving a 12mg/weekly dose of retatrutide were [21]: Nausea (45% of participants) Vomiting (19%) Constipation (16%) Diarrhea (15%) Cardiac arrhythmia (11%) Fatigue (10%) Increased pancreatic enzyme (lipase) levels (8%) Injection site reactions (8%) Liver issues in 2 participants (3%) Pancreatitis in 1 participant (2%) Both tirzepatide and retatrutide share similar contraindications, including advice against their use during pregnancy and breastfeeding

clinical trial registration number NCT02759107) (57)

Prescribed by U.S

This is not a GLP-1 receptor agonist